- Home
- OGEN vs YCBD Comparison
OGEN vs YCBD Comparison
Compare OGEN & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- YCBD
- Stock Information
- Founded
- OGEN 1996
- YCBD 2015
- Country
- OGEN United States
- YCBD United States
- Employees
- OGEN N/A
- YCBD N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- OGEN Health Care
- YCBD Health Care
- Exchange
- OGEN Nasdaq
- YCBD Nasdaq
- Market Cap
- OGEN 3.9M
- YCBD 3.2M
- IPO Year
- OGEN N/A
- YCBD N/A
- Fundamental
- Price
- OGEN $0.29
- YCBD $0.45
- Analyst Decision
- OGEN
- YCBD
- Analyst Count
- OGEN 0
- YCBD 0
- Target Price
- OGEN N/A
- YCBD N/A
- AVG Volume (30 Days)
- OGEN 14.3M
- YCBD 2.0M
- Earning Date
- OGEN 03-28-2025
- YCBD 02-13-2025
- Dividend Yield
- OGEN N/A
- YCBD N/A
- EPS Growth
- OGEN N/A
- YCBD N/A
- EPS
- OGEN N/A
- YCBD N/A
- Revenue
- OGEN N/A
- YCBD $19,220,238.00
- Revenue This Year
- OGEN N/A
- YCBD $13.00
- Revenue Next Year
- OGEN N/A
- YCBD $10.00
- P/E Ratio
- OGEN N/A
- YCBD N/A
- Revenue Growth
- OGEN N/A
- YCBD N/A
- 52 Week Low
- OGEN $0.25
- YCBD $0.31
- 52 Week High
- OGEN $3.84
- YCBD $1.34
- Technical
- Relative Strength Index (RSI)
- OGEN 46.16
- YCBD 42.04
- Support Level
- OGEN $0.28
- YCBD $0.42
- Resistance Level
- OGEN $0.31
- YCBD $0.69
- Average True Range (ATR)
- OGEN 0.05
- YCBD 0.06
- MACD
- OGEN 0.00
- YCBD -0.02
- Stochastic Oscillator
- OGEN 9.39
- YCBD 10.98
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.